Lantern Pharma Inc. (LTRN)

CIK 1763950 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lantern Pharma Inc..

Recent SEC filings

FiledFormAccession number
Oct 21, 2026ARS0001493152-26-047808
Oct 19, 2026DEF 14A0001493152-26-047586
Oct 13, 2026SCHEDULE 13G/A0000919574-26-006874
Oct 8, 2026PRE 14A0001493152-26-046325
Oct 1, 20268-K0001493152-26-045344
Sep 30, 2026424B50001493152-26-045049
Sep 30, 20268-K0001493152-26-045100
Sep 24, 20268-K0001493152-26-044007
Sep 23, 20268-K0001493152-26-043808
Aug 14, 20268-K0001493152-26-037979
Aug 14, 202610-Q0001493152-26-037971
Aug 4, 2026SCHEDULE 13G0000919574-26-004747
Aug 3, 20268-K0001493152-26-035864
Jul 23, 2026SCHEDULE 13G/A0001104659-26-086180
Jun 18, 2026EFFECT9999999995-26-002072
Jun 12, 2026S-10001493152-26-028460
Jun 2, 20268-K0001493152-26-026696
May 21, 2026D0001493152-26-024786
May 15, 20268-K0001493152-26-023758
May 15, 202610-Q0001493152-26-023740
May 15, 2026SCHEDULE 13D/A0001813314-26-000008
May 14, 202640001493152-26-023083
May 14, 202640001493152-26-023082
May 14, 2026424B50001493152-26-022895
May 14, 20268-K0001493152-26-023200